Medications to treat myocardial ischemia include:?Aspirin. A daily aspirin or other blood thinner can reduce your risk of blood clots, which might help prevent blockage of your coronary arteries.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Myocardial Ischemia Drugs industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
BAY-606583
CMK-103
DT-010
Humanin
Others
Market Segment by Product Application
Hospital
Clinic
Others
Finally, the report provides detailed profile and data information analysis of leading company.
Baxalta Incorporated
Bayer AG
Cellmid Limited
CohBar, Inc.
Lixte Biotechnology Holdings, Inc.
NoNO, Inc.
Symic Biomedical, Inc.
Taxus Cardium Pharmaceuticals Group Inc.
ViroMed Co., Ltd.
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Myocardial Ischemia Drugs consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Myocardial Ischemia Drugs market by identifying its various subsegments.
3.Focuses on the key global Myocardial Ischemia Drugs manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Myocardial Ischemia Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Myocardial Ischemia Drugs submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Myocardial Ischemia Drugs Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Myocardial Ischemia Drugs Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Myocardial Ischemia Drugs Segment by Type
2.1.1 BAY-606583
2.1.2 CMK-103
2.1.3 DT-010
2.1.4 Humanin
2.1.5 Others
2.2 Market Analysis by Application
2.2.1 Hospital
2.2.2 Clinic
2.2.3 Others
2.3 Global Myocardial Ischemia Drugs Market Comparison by Regions (2017-2027)
2.3.1 Global Myocardial Ischemia Drugs Market Size (2017-2027)
2.3.2 North America Myocardial Ischemia Drugs Status and Prospect (2017-2027)
2.3.3 Europe Myocardial Ischemia Drugs Status and Prospect (2017-2027)
2.3.4 China Myocardial Ischemia Drugs Status and Prospect (2017-2027)
2.3.5 Japan Myocardial Ischemia Drugs Status and Prospect (2017-2027)
2.3.6 Southeast Asia Myocardial Ischemia Drugs Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Myocardial Ischemia Drugs Industry Impact
2.5.1 Myocardial Ischemia Drugs Business Impact Assessment - Covid-19
2.5.2 Market Trends and Myocardial Ischemia Drugs Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Myocardial Ischemia Drugs Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Myocardial Ischemia Drugs Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Myocardial Ischemia Drugs Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Myocardial Ischemia Drugs Manufacturer Market Share
3.5 Top 10 Myocardial Ischemia Drugs Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Myocardial Ischemia Drugs Market
3.7 Key Manufacturers Myocardial Ischemia Drugs Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Myocardial Ischemia Drugs Industry Key Manufacturers
4.1 Baxalta Incorporated
4.1.1 Compan Detail
4.1.2 Baxalta Incorporated Myocardial Ischemia Drugs Product Introduction, Application and Specification
4.1.3 Baxalta Incorporated 138 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Baxalta Incorporated News
4.2 Bayer AG
4.2.1 Compan Detail
4.2.2 Bayer AG Myocardial Ischemia Drugs Product Introduction, Application and Specification
4.2.3 Bayer AG Myocardial Ischemia Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Baxalta Incorporated News
4.3 Cellmid Limited
4.3.1 Compan Detail
4.3.2 Cellmid Limited Myocardial Ischemia Drugs Product Introduction, Application and Specification
4.3.3 Cellmid Limited Myocardial Ischemia Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Cellmid Limited News
4.4 CohBar, Inc.
4.4.1 Compan Detail
4.4.2 CohBar, Inc. Myocardial Ischemia Drugs Product Introduction, Application and Specification
4.4.3 CohBar, Inc. Myocardial Ischemia Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 CohBar, Inc. News
4.5 Lixte Biotechnology Holdings, Inc.
4.5.1 Compan Detail
4.5.2 CohBar, Inc. Myocardial Ischemia Drugs Product Introduction, Application and Specification
4.5.3 Lixte Biotechnology Holdings, Inc. Myocardial Ischemia Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Lixte Biotechnology Holdings, Inc. News
4.6 NoNO, Inc.
4.6.1 Compan Detail
4.6.2 NoNO, Inc. Myocardial Ischemia Drugs Product Introduction, Application and Specification
4.6.3 NoNO, Inc. Myocardial Ischemia Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 NoNO, Inc. News
4.7 Symic Biomedical, Inc.
4.7.1 Compan Detail
4.7.2 Symic Biomedical, Inc. Myocardial Ischemia Drugs Product Introduction, Application and Specification
4.7.3 Symic Biomedical, Inc. Myocardial Ischemia Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Taxus Cardium Pharmaceuticals Group Inc.
4.8.1 Compan Detail
4.8.2 Taxus Cardium Pharmaceuticals Group Inc. Myocardial Ischemia Drugs Product Introduction, Application and Specification
4.8.3 Taxus Cardium Pharmaceuticals Group Inc. Myocardial Ischemia Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Taxus Cardium Pharmaceuticals Group Inc. News
4.9 ViroMed Co., Ltd.
4.9.1 Compan Detail
4.9.2 ViroMed Co., Ltd. Myocardial Ischemia Drugs Product Introduction, Application and Specification
4.9.3 ViroMed Co., Ltd. Myocardial Ischemia Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 ViroMed Co., Ltd. News
5 Global Myocardial Ischemia Drugs Market Segment by Big Type
5.1 Global Myocardial Ischemia Drugs Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Myocardial Ischemia Drugs Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Myocardial Ischemia Drugs Revenue and Market Share by Big Type (2017-2022)
5.2 BAY-606583 Sales Growth Rate and Price
5.2.1 Global BAY-606583 Sales Growth Rate (2017-2022)
5.2.2 Global BAY-606583 Price (2017-2022)
5.3 CMK-103 Sales Growth Rate and Price
5.3.1 Global CMK-103 Sales Growth Rate (2017-2022)
5.3.2 Global CMK-103 Price (2017-2022)
5.4 DT-010 Sales Growth Rate and Price
5.4.1 Global DT-010 Sales Growth Rate (2017-2022)
5.4.2 Global DT-010 Price (2017-2022)
5.5 Humanin Sales Growth Rate and Price
5.5.1 Global Humanin Sales Growth Rate (2017-2022)
5.5.2 Global Humanin Price (2017-2022)
5.6 Others Sales Growth Rate and Price
5.6.1 Global Others Sales Growth Rate (2017-2022)
5.6.2 Global Others Price (2017-2022)
6 Global Myocardial Ischemia Drugs Market Segment by Big Application
6.1 Global Myocardial Ischemia Drugs Sales Market Share by Big Application (2017-2022)
6.2 Hospital Sales Growth Rate (2017-2022)
6.3 Clinic Sales Growth Rate (2017-2022)
6.4 Others Sales Growth Rate (2017-2022)
7 Global Myocardial Ischemia Drugs Forecast
7.1 Global Myocardial Ischemia Drugs Revenue, Sales and Growth Rate (2022-2027)
7.2 Myocardial Ischemia Drugs Market Forecast by Regions (2022-2027)
7.2.1 North America Myocardial Ischemia Drugs Market Forecast (2022-2027)
7.2.2 Europe Myocardial Ischemia Drugs Market Forecast (2022-2027)
7.2.3 China Myocardial Ischemia Drugs Market Forecast (2022-2027)
7.2.4 Japan Myocardial Ischemia Drugs Market Forecast (2022-2027)
7.2.5 Southeast Asia Myocardial Ischemia Drugs Market Forecast (2022-2027)
7.2.6 Other Regions Myocardial Ischemia Drugs Market Forecast (2022-2027)
7.3 Myocardial Ischemia Drugs Market Forecast by Type (2022-2027)
7.3.1 Global Myocardial Ischemia Drugs Sales Forecast by Type (2022-2027)
7.3.2 Global Myocardial Ischemia Drugs Market Share Forecast by Type (2022-2027)
7.4 Myocardial Ischemia Drugs Market Forecast by Application (2022-2027)
7.4.1 Global Myocardial Ischemia Drugs Sales Forecast by Application (2022-2027)
7.4.2 Global Myocardial Ischemia Drugs Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Myocardial Ischemia Drugs Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Myocardial Ischemia Drugs Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Myocardial Ischemia Drugs
Figure Market Concentration Ratio and Market Maturity Analysis of Myocardial Ischemia Drugs
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Myocardial Ischemia Drugs Market Size by Big Type
Figure Global Market Share of Myocardial Ischemia Drugs by Big Type in 2021
Figure BAY-606583 Picture (2017-2022)
Figure CMK-103 Picture (2017-2022)
Figure DT-010 Picture (2017-2022)
Figure Humanin Picture (2017-2022)
Global Myocardial Ischemia Drugs Market Size by Big Application
Table Global Myocardial Ischemia Drugs Market Size by Application
Figure Global Myocardial Ischemia Drugs Market Share by Big Application in 2021
Figure Hospital Picture
Figure Clinic Picture
Figure Others Picture
Table Global Myocardial Ischemia Drugs Comparison by Regions (M USD) (2017-2027)
Figure Global Myocardial Ischemia Drugs Market Size (Million US$) (2017-2027)
Figure North America Myocardial Ischemia Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Myocardial Ischemia Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure China Myocardial Ischemia Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Myocardial Ischemia Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Myocardial Ischemia Drugs Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Myocardial Ischemia Drugs Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Myocardial Ischemia Drugs Sales by Manufacturer (2017-2022)
Figure Global Myocardial Ischemia Drugs Sales Market Share by Manufacturer in 2021
Table Global Myocardial Ischemia Drugs Revenue by Manufacturer (2017-2022)
Figure Global Myocardial Ischemia Drugs Revenue Market Share by Manufacturer in 2021
Table Global Myocardial Ischemia Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Myocardial Ischemia Drugs Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Myocardial Ischemia Drugs Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Myocardial Ischemia Drugs Market
Table Key Manufacturers Myocardial Ischemia Drugs Product Type
Table Mergers & Acquisitions Planning
Table Baxalta Incorporated Company Profile
Table Myocardial Ischemia Drugs Product Introduction, Application and Specification of Baxalta Incorporated
Table Myocardial Ischemia Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Bayer AG Company Profile
Table Myocardial Ischemia Drugs Product Introduction, Application and Specification of Bayer AG
Table Myocardial Ischemia Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bayer AG Recent Development
Table Cellmid Limited Company Profile
Table Myocardial Ischemia Drugs Product Introduction, Application and Specification of Cellmid Limited
Table Myocardial Ischemia Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Cellmid Limited Main Business
Table Cellmid Limited Recent Development
Table CohBar, Inc. Company Profile
Table Myocardial Ischemia Drugs Product Introduction, Application and Specification of CohBar, Inc.
Table Myocardial Ischemia Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table CohBar, Inc. Main Business
Table CohBar, Inc. Recent Development
Table CohBar, Inc. Main Business
Table CohBar, Inc. Recent Development
Table Lixte Biotechnology Holdings, Inc. Company Profile
Table Myocardial Ischemia Drugs Product Introduction, Application and Specification of Lixte Biotechnology Holdings, Inc.
Table Myocardial Ischemia Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Lixte Biotechnology Holdings, Inc. Main Business
Table Lixte Biotechnology Holdings, Inc. Recent Development
Table NoNO, Inc. Company Profile
Table Myocardial Ischemia Drugs Product Introduction, Application and Specification of NoNO, Inc.
Table Myocardial Ischemia Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table NoNO, Inc. Main Business
Table NoNO, Inc. Recent Development
Table Symic Biomedical, Inc. Company Profile
Table Myocardial Ischemia Drugs Product Introduction, Application and Specification of Symic Biomedical, Inc.
Table Myocardial Ischemia Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Symic Biomedical, Inc. Main Business
Table Symic Biomedical, Inc. Recent Development
Table Taxus Cardium Pharmaceuticals Group Inc. Company Profile
Table Myocardial Ischemia Drugs Product Introduction, Application and Specification of Taxus Cardium Pharmaceuticals Group Inc.
Table Myocardial Ischemia Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Taxus Cardium Pharmaceuticals Group Inc. Main Business
Table Taxus Cardium Pharmaceuticals Group Inc. Recent Development
Table ViroMed Co., Ltd. Company Profile
Table Myocardial Ischemia Drugs Product Introduction, Application and Specification of ViroMed Co., Ltd.
Table Myocardial Ischemia Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table ViroMed Co., Ltd. Main Business
Table ViroMed Co., Ltd. Recent Development
Figure Global Myocardial Ischemia Drugs Sales and Growth Rate (2017-2022)
Figure Global Myocardial Ischemia Drugs Revenue and Growth Rate (2017-2022)
Table Global Myocardial Ischemia Drugs Sales by Regions (2017-2022)
Figure Global Myocardial Ischemia Drugs Sales Market Share by Regions in 2021
Table Global Myocardial Ischemia Drugs Revenue by Regions (2017-2022)
Figure Global Myocardial Ischemia Drugs Revenue Market Share by Regions in 2021
Figure North America Myocardial Ischemia Drugs Sales and Growth Rate (2017-2022)
Figure Europe Myocardial Ischemia Drugs Sales and Growth Rate (2017-2022)
Figure China Myocardial Ischemia Drugs Sales and Growth Rate (2017-2022)
Figure Japan Myocardial Ischemia Drugs Sales and Growth Rate (2017-2022)
Figure Southeast Asia Myocardial Ischemia Drugs Sales and Growth Rate (2017-2022)
Figure Other Regions Myocardial Ischemia Drugs Sales and Growth Rate (2017-2022)
Table Global Myocardial Ischemia Drugs Sales by Big Type (2017-2022)
Table Global Myocardial Ischemia Drugs Sales Market Share by Big Type (2017-2022)
Figure Global Myocardial Ischemia Drugs Sales Market Share by Big Type in 2019
Table Global Myocardial Ischemia Drugs Revenue by Big Type (2017-2022)
Table Global Myocardial Ischemia Drugs Revenue Market Share by Big Type (2017-2022)
Table Global Myocardial Ischemia Drugs Revenue Market Share by Big Type in 2019
Figure Global BAY-606583 Sales Growth Rate (2017-2022)
Figure Global BAY-606583 Price (2017-2022)
Figure Global CMK-103 Sales Growth Rate (2017-2022)
Figure Global CMK-103 Price (2017-2022)
Figure Global DT-010 Sales Growth Rate (2017-2022)
Figure Global DT-010 Price (2017-2022)
Figure Global Humanin Sales Growth Rate (2017-2022)
Figure Global Humanin Price (2017-2022)
Table Global Myocardial Ischemia Drugs Sales by Big Application (2017-2022)
Table Global Myocardial Ischemia Drugs Sales Market Share by Big Application (2017-2022)
Figure Global Myocardial Ischemia Drugs Sales Market Share by Big Application in 2019
Figure Global Hospital Sales Growth Rate (2017-2022)
Figure Global Clinic Sales Growth Rate (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Figure Global Myocardial Ischemia Drugs Sales and Growth Rate (2022-2027)
Figure Global Myocardial Ischemia Drugs Revenue and Growth Rate (2022-2027)
Table Global Myocardial Ischemia Drugs Sales Forecast by Regions (2022-2027)
Table Global Myocardial Ischemia Drugs Market Share Forecast by Regions (2022-2027)
Figure North America Sales Myocardial Ischemia Drugs Market Forecast (2022-2027)
Figure Europe Sales Myocardial Ischemia Drugs Market Forecast (2022-2027)
Figure China Sales Myocardial Ischemia Drugs Market Forecast (2022-2027)
Figure Japan Sales Myocardial Ischemia Drugs Market Forecast (2022-2027)
Figure Southeast Asia Sales Myocardial Ischemia Drugs Market Forecast (2022-2027)
Figure Other Regions Sales Myocardial Ischemia Drugs Market Forecast (2022-2027)
Table Global Myocardial Ischemia Drugs Sales Forecast by Type (2022-2027)
Table Global Myocardial Ischemia Drugs Market Share Forecast by Type (2022-2027)
Table Global Myocardial Ischemia Drugs Sales Forecast by Application (2022-2027)
Table Global Myocardial Ischemia Drugs Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Myocardial Ischemia Drugs
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Myocardial Ischemia Drugs Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Myocardial Ischemia Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Myocardial Ischemia Drugs Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Myocardial Ischemia Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Myocardial Ischemia Drugs Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Myocardial Ischemia Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Myocardial Ischemia Drugs Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Myocardial Ischemia Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Baxalta Incorporated
Bayer AG
Cellmid Limited
CohBar, Inc.
Lixte Biotechnology Holdings, Inc.
NoNO, Inc.
Symic Biomedical, Inc.
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)